Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · IEX Real-Time Price · USD
2.730
+0.030 (1.11%)
Jul 22, 2024, 10:10 AM EDT - Market open

Catheter Precision Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2016
Cash & Equivalents
1.493.5715.8615.0523.9114.58
Upgrade
Short-Term Investments
0000015.99
Upgrade
Cash & Cash Equivalents
1.493.5715.8615.0523.9130.58
Upgrade
Cash Growth
-87.80%-77.52%5.41%-37.07%-21.82%-52.46%
Upgrade
Receivables
0.070.1400.020.020.79
Upgrade
Inventory
0.060.0400.990.882.78
Upgrade
Other Current Assets
0.330.420.981.042.811.86
Upgrade
Total Current Assets
1.954.1616.8417.0927.6236
Upgrade
Property, Plant & Equipment
0.250.2503.925.017.89
Upgrade
Goodwill and Intangibles
25.8126.320000
Upgrade
Other Long-Term Assets
0.010.0100.040.810.2
Upgrade
Total Long-Term Assets
26.0726.5803.965.828.08
Upgrade
Total Assets
28.0230.7416.8421.0433.4444.08
Upgrade
Accounts Payable
7.67.440.090.990.471.53
Upgrade
Deferred Revenue
000003.26
Upgrade
Current Debt
0.170.2800.281.040.61
Upgrade
Other Current Liabilities
-5.42-5.247.484.126.251.41
Upgrade
Total Current Liabilities
2.352.477.585.397.766.81
Upgrade
Long-Term Debt
0.090.101.983.842.89
Upgrade
Other Long-Term Liabilities
7.066.97000.691.23
Upgrade
Total Long-Term Liabilities
7.157.0701.984.534.12
Upgrade
Total Liabilities
9.59.547.587.3712.2910.93
Upgrade
Total Debt
0.250.3702.264.893.5
Upgrade
Debt Growth
82.73%---53.65%39.73%311.29%
Upgrade
Retained Earnings
-278.38-275.71-205.14-178.27-153.2-117.16
Upgrade
Comprehensive Income
000000.03
Upgrade
Shareholders' Equity
18.5221.199.2613.6721.1533.15
Upgrade
Net Cash / Debt
1.243.1915.8612.7819.0227.08
Upgrade
Net Cash / Debt Growth
-89.76%-79.87%24.08%-32.81%-29.76%-57.33%
Upgrade
Net Cash Per Share
1.675.81153.401265.455597.7025742.40
Upgrade
Working Capital
-0.41.699.2611.719.8629.19
Upgrade
Book Value Per Share
24.9338.5789.571353.766223.3731511.41
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).